Stuttgart - Delayed Quote EUR
Vertex Pharmaceuticals Inc (VX1.SG)
430.75
-2.15
(-0.50%)
As of 8:01:23 AM GMT+2. Market Open.
Loading Chart for VX1.SG
- Previous Close
432.90 - Open
430.75 - Bid 430.25 x 50000
- Ask 433.35 x 100000
- Day's Range
430.75 - 430.75 - 52 Week Range
365.00 - 489.95 - Volume
0 - Avg. Volume
48 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: VX1.SG
View MorePerformance Overview: VX1.SG
Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
VX1.SG
10.66%
S&P 500 (^GSPC)
8.60%
1-Year Return
VX1.SG
14.96%
S&P 500 (^GSPC)
6.00%
3-Year Return
VX1.SG
70.02%
S&P 500 (^GSPC)
25.85%
5-Year Return
VX1.SG
72.13%
S&P 500 (^GSPC)
89.51%
Compare To: VX1.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VX1.SG
View MoreValuation Measures
As of 4/23/2025
Market Cap
111.53B
Enterprise Value
107.68B
Trailing P/E
--
Forward P/E
27.86
PEG Ratio (5yr expected)
1.35
Price/Sales (ttm)
11.50
Price/Book (mrq)
7.70
Enterprise Value/Revenue
11.09
Enterprise Value/EBITDA
251.34
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--